Vita Dolžan

Metabolic gene polymorphism frequencies in control populations.

Seymour Garte, Laura Gaspari, Anna-Karin Alexandrie et al. · PubMed · 2001 · 847 citations

Genetics, Genetic Epidemiology, Human Polymorphism +17

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Cathelijne H. van der Wouden, Anne Cambon‐Thomsen, Erika Cecchin et al. · Clinical Pharmacology & Therapeutics · 2016 · 288 citations · Full text

Relevant Pgx-markers, Genetic Epidemiology, Ubiquitous Pharmacogenomics +22

Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk

Simone Benhamou, Won Jin Lee, Anna-Karin Alexandrie et al. · Carcinogenesis · 2002 · 255 citations · Full text

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

Clint Mizzi, Eleni Dalabira, Judit Kumuthini et al. · PLoS ONE · 2016 · 153 citations · Full text

Genetic Epidemiology, Genome-wide Association Study, Biomarker (Medicine) +18